Treatment of pediatric pyogenic granulomas using β-adrenergic receptor antagonists

Pediatric Dermatology

Volumn 31, Issue 2, 2014, Pages 203-207

  Wine Lee, Lara ^a   Goff, Kiera L ^b   Lam, Joseph M ^c   Low, David W ^a   Yan, Albert C ^a   Castelo Soccio, Leslie ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; PROPRANOLOL; TIMOLOL;

ARTICLE; CAPILLARY HEMANGIOMA; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; FEMALE; HUMAN; LOBULAR CAPILLARY HEMANGIOMA; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PYOGENIC GRANULOMA; SCHOOL CHILD; GRANULOMA, PYOGENIC; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; ADRENERGIC BETA-ANTAGONISTS; CHILD; CHILD, PRESCHOOL; FEMALE; GRANULOMA, PYOGENIC; HUMANS; MALE; PROPRANOLOL; TIMOLOL; TREATMENT OUTCOME;

EID: 84895923718     PISSN: 07368046     EISSN: 15251470     Source Type: Journal    
DOI: 10.1111/pde.12217     Document Type: Article

References (15)

1. Greenberger S, Bischoff J,. Infantile hemangioma-mechanism(s) of drug action on a vascular tumor. Cold Spring Harb Perspect Med 2011; 1: a006460.
2. Léauté-Labrèze C, Dumas de la Roque E, Hubiche T, et al. Propranolol for severe hemangiomas of infancy. N Engl J Med 2008; 358: 2649-2651.
3. Moehrle M, Léauté-Labrèze C, Schmidt V, et al. Topical timolol for small hemangiomas of infancy. Pediatr Dermatol 2013; 30: 245-249.
4. Kunzi-Rapp K,. Topical propranolol therapy for infantile hemangiomas. Pediatr Dermatol 2012; 29: 154-159.
5. Chakkittakandiyil A, Phillips R, Frieden IJ, et al. Timolol maleate 0.5% or 0.1% gel-forming solution for infantile hemangiomas: a retrospective, multicenter, cohort study. Pediatr Dermatol 2012; 29: 28-31.
6. Lee J, Sinno H, Tahiri Y, et al. Treatment options for cutaneous pyogenic granulomas: a review. J Plast Reconstr Aesthet Surg 2011; 64: 1216-1220.
7. Giblin AV, Clover AJP, Athanassopoulos A, et al. Pyogenic granuloma-the quest for optimum treatment: audit of treatment of 408 cases. J Plast Reconstr Aesthet Surg 2007; 60: 1030-1035.
8. Yuan K, Jin YT, Lin MT,. The detection and comparison of angiogenesis-associated factors in pyogenic granuloma by immunohistochemistry. J Periodontol 2000; 71: 701-709.
9. Bragado R, Bello E, Requena L, et al. Increased expression of vascular endothelial growth factor in pyogenic granulomas. Acta Derm Venereol 1999; 79: 422-425.
10. Freitas TMC, Miguel MCC, Silveira EJD, et al. Assessment of angiogenic markers in oral hemangiomas and pyogenic granulomas. Exp Mol Pathol 2005; 79: 79-85.
11. Chisholm KM, Chang KW, Truong MT, et al. β-adrenergic receptor expression in vascular tumors. Mod Pathol 2012; 25: 1446-1451.
12. McMahon P, Oza V, Frieden IJ,. Topical timolol for infantile hemangiomas: putting a note of caution in "cautiously optimistic." Pediatr Dermatol 2012; 29: 127-130.
13. Lee N, Isenstein A, Zedek D, et al. A case of childhood subcutaneous pyogenic granuloma (lobular capillary hemangioma). Clin Pediatr (Phila) 2012; 51: 88-90.
14. Truong MT, Perkins JA, Messner AH, et al. Propranolol for the treatment of airway hemangiomas: a case series and treatment algorithm. Int J Pediatr Otorhinolaryngol 2010; 74: 1043-1048.
15. Baselga E, Wassef M, Lopez S, et al. Agminated, eruptive pyogenic granuloma-like lesions developing over congenital vascular stains. Pediatr Dermatol 2012; 29: 186-190.